Summary & Overview
HCPCS Level II M1224: Intraocular Pressure Reduction <20% Post-Intervention
HCPCS Level II code M1224 denotes an outcome-based measure: intraocular pressure (IOP) reduced by less than 20% from the pre-intervention level. As an outcome code for ophthalmic care, it captures suboptimal or modest pressure-lowering results after procedures or therapies designed to lower IOP, and is relevant for clinical documentation, quality measurement, and encounter reporting across outpatient ophthalmology settings nationwide. Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise overview of the code’s clinical meaning and typical use case, guidance on where it is commonly reported (ophthalmology clinics and ambulatory procedure settings), and what to expect in accompanying documentation. The publication outlines benchmarking considerations, common modifier usage (listed separately), and the clinical context in which a less-than-20% IOP reduction is recorded. It also notes where specific payer policy or coverage details are not available. The goal is to provide clinicians, coders, and policy staff with clear, actionable information about HCPCS Level II code M1224 to support accurate reporting and interpretation at a national level.
Billing Code Overview
HCPCS Level II code M1224 describes a clinical outcome where intraocular pressure (IOP) is reduced by a value less than 20% from the pre-intervention level. This code is used to report a quantified IOP reduction outcome following an ocular pressure-lowering intervention.
-
Service type: Measurement of intraocular pressure response after an intervention
-
Typical site of service: Ophthalmology clinic or ambulatory surgical/procedure setting where post-intervention IOP is assessed
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with primary open-angle glaucoma presents for a postoperative assessment following an intraocular pressure (IOP) lowering intervention (for example, selective laser trabeculoplasty or minimally invasive glaucoma surgery). Pre-intervention IOP was 24 mmHg on topical therapy. At the follow-up visit, measured IOP is 20 mmHg, representing a reduction of less than 20% from baseline. The clinical workflow includes: initial history and medication review, Snellen visual acuity, slit-lamp exam, gonioscopy as indicated, Goldmann applanation tonometry to document IOP, assessment of optic nerve and visual fields, documentation of ongoing glaucoma therapy, and decision-making regarding further treatment or observation. The provider documents the percent IOP reduction, compares to the pre-intervention baseline, and codes the visit and any procedures accordingly. Typical site of service is an outpatient ophthalmology clinic or ambulatory surgery center for the intervention; follow-up measurement and coding occur in the same outpatient ophthalmology setting.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required is substantially greater than typically required for the procedure due to complexity or complications. |
23 |